Next Steps For NuVasive Following CEO Resignation

The resignation of CEO Alex Lukianov could signal a shift in the spine firm's approach to sales and profitability that could ultimately make NuVasive as a more attractive acquisition candidate.

More from Archive

More from Medtech Insight